Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Neogen Corporation (NEOG : NSDQ)
 
 • Company Description   
Neogen Corporation develops, manufactures and markets a diverse line of products dedicated to food and animal safety. The Company's Lansing, Mich.-based Food Safety Division develops and markets dehydrated culture media, and rapid diagnostic test kits to detect foodborne bacteria, spoilage organisms, mycotoxins, food allergens, genetic modifications, drug residues, plant diseases, and sanitation concerns. Neogen's is the leading global provider of DNA testing for animal agribusiness and veterinary medicine. Neogen understands that its customers face serious consequences if their products are contaminated with any of a number of well-established or emerging threats, including dangerous bacteria, natural toxins, veterinary drug residues, unlabeled food allergens, rodent filth, sanitation concerns, broken veterinary needles or other contaminants.

Number of Employees: 1,841

 
 • Price / Volume Information   
Yesterday's Closing Price: $26.48 Daily Weekly Monthly
20 Day Moving Average: 615,132 shares
Shares Outstanding: 107.82 (millions)
Market Capitalization: $2,855.02 (millions)
Beta: 0.60
52 Week High: $47.33
52 Week Low: $24.90
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -11.91% -3.84%
12 Week -24.82% -18.74%
Year To Date -41.69% -30.93%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
620 LESHER PLACE
-
LANSING,MI 48912
USA
ph: 517-372-9200
fax: 517-372-2006
ir@neogen.com http://www.neogen.com
 
 • General Corporate Information   
Officers
John E. Adent - Chief Executive Officer and President
James C. Borel - Chairman
Steven J. Quinlan - Vice President & Chief Financial Officer
William T. Boehm - Director
Ronald D. Green - Director

Peer Information
Neogen Corporation (BJCT)
Neogen Corporation (CADMQ)
Neogen Corporation (APNO)
Neogen Corporation (UPDC)
Neogen Corporation (IMTIQ)
Neogen Corporation (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 640491106
SIC: 2835
Fiscal Year
Fiscal Year End: May
Last Reported Quarter: 02/01/22
Next Expected EPS Date: 07/19/22
Share - Related Items
Shares Outstanding: 107.82
Most Recent Split Date: 6.00 (2.00:1)
Beta: 0.60
Market Capitalization: $2,855.02 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.16 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.61 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/19/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 43.41
Trailing 12 Months: 43.41
PEG Ratio: -
Price Ratios
Price/Book: 3.26
Price/Cash Flow: 34.59
Price / Sales: 5.55
EPS Growth
vs. Year Ago Period: 4.00%
vs. Previous Quarter: -23.53%
Sales Growth
vs. Year Ago Period: 9.88%
vs. Previous Quarter: -1.74%
ROE
02/28/22 - 7.51
11/30/21 - 7.64
08/31/21 - 7.57
ROA
02/28/22 - 6.79
11/30/21 - 6.95
08/31/21 - 6.94
Current Ratio
02/28/22 - 9.28
11/30/21 - 9.75
08/31/21 - 12.00
Quick Ratio
02/28/22 - 7.55
11/30/21 - 8.04
08/31/21 - 9.99
Operating Margin
02/28/22 - 12.54
11/30/21 - 12.79
08/31/21 - 12.74
Net Margin
02/28/22 - 9.55
11/30/21 - 11.34
08/31/21 - 12.74
Pre-Tax Margin
02/28/22 - 11.94
11/30/21 - 14.07
08/31/21 - 15.84
Book Value
02/28/22 - 8.12
11/30/21 - 8.03
08/31/21 - 7.96
Inventory Turnover
02/28/22 - 2.63
11/30/21 - 2.65
08/31/21 - 2.66
Debt-to-Equity
02/28/22 - 0.00
11/30/21 - 0.00
08/31/21 - 0.00
Debt-to-Capital
02/28/22 - 0.00
11/30/21 - 0.00
08/31/21 - 0.00
 

Powered by Zacks Investment Research ©